POSTERIOR CAPSULOTOMY CYSTITOME— 510(k) K840660

Substantially Equivalent

Sharpoint, Inc.

FDA 510(k) clearance K840660 for POSTERIOR CAPSULOTOMY CYSTITOME, Substantially Equivalent on 1984-03-16. Applicant: Sharpoint, Inc..

Clearance details

Applicant: Sharpoint, Inc.
Product code: Code HNY
Advisory panel: Ophthalmic
Date received: 1984-02-15
Decision date: 1984-03-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.